133 related articles for article (PubMed ID: 31611954)
1. Extracellular AGR3 regulates breast cancer cells migration via Src signaling.
Obacz J; Sommerova L; Sicari D; Durech M; Avril T; Iuliano F; Pastorekova S; Hrstka R; Chevet E; Delom F; Fessart D
Oncol Lett; 2019 Nov; 18(5):4449-4456. PubMed ID: 31611954
[TBL] [Abstract][Full Text] [Related]
2. Anterior Gradient-3: a novel biomarker for ovarian cancer that mediates cisplatin resistance in xenograft models.
Gray TA; MacLaine NJ; Michie CO; Bouchalova P; Murray E; Howie J; Hrstka R; Maslon MM; Nenutil R; Vojtesek B; Langdon S; Hayward L; Gourley C; Hupp TR
J Immunol Methods; 2012 Apr; 378(1-2):20-32. PubMed ID: 22361111
[TBL] [Abstract][Full Text] [Related]
3. Anterior gradient protein 3 is associated with less aggressive tumors and better outcome of breast cancer patients.
Obacz J; Brychtova V; Podhorec J; Fabian P; Dobes P; Vojtesek B; Hrstka R
Onco Targets Ther; 2015; 8():1523-32. PubMed ID: 26170690
[TBL] [Abstract][Full Text] [Related]
4. Over-expression of Anterior Gradient 3 Is Associated With Tumor Progression and Poor Survival in Gastric Cancer.
Lee WS; Park SY; Park YL; Joo YE
In Vivo; 2023; 37(1):483-489. PubMed ID: 36593009
[TBL] [Abstract][Full Text] [Related]
5. The role of AGR2 and AGR3 in cancer: similar but not identical.
Obacz J; Takacova M; Brychtova V; Dobes P; Pastorekova S; Vojtesek B; Hrstka R
Eur J Cell Biol; 2015; 94(3-4):139-47. PubMed ID: 25666661
[TBL] [Abstract][Full Text] [Related]
6. AGR3 promotes estrogen receptor-positive breast cancer cell proliferation in an estrogen-dependent manner.
Jian L; Xie J; Guo S; Yu H; Chen R; Tao K; Yang C; Li K; Liu S
Oncol Lett; 2020 Aug; 20(2):1441-1451. PubMed ID: 32724387
[TBL] [Abstract][Full Text] [Related]
7. AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detection.
Garczyk S; von Stillfried S; Antonopoulos W; Hartmann A; Schrauder MG; Fasching PA; Anzeneder T; Tannapfel A; Ergönenc Y; Knüchel R; Rose M; Dahl E
PLoS One; 2015; 10(4):e0122106. PubMed ID: 25875093
[TBL] [Abstract][Full Text] [Related]
8. AGR2-AGR3 hetero-oligomeric complexes: Identification and characterization.
Černocká H; Vonka P; Kasalová V; Sommerova L; Vandova V; Hrstka R; Ostatna V
Bioelectrochemistry; 2021 Aug; 140():107808. PubMed ID: 33848875
[TBL] [Abstract][Full Text] [Related]
9. The Endoplasmic Reticulum Resident Protein AGR3. Required for Regulation of Ciliary Beat Frequency in the Airway.
Bonser LR; Schroeder BW; Ostrin LA; Baumlin N; Olson JL; Salathe M; Erle DJ
Am J Respir Cell Mol Biol; 2015 Oct; 53(4):536-43. PubMed ID: 25751668
[TBL] [Abstract][Full Text] [Related]
10. Secreted AGR2 promotes invasion of colorectal cancer cells via Wnt11-mediated non-canonical Wnt signaling.
Tian S; Hu J; Tao K; Wang J; Chu Y; Li J; Liu Z; Ding X; Xu L; Li Q; Cai M; Gao J; Shuai X; Wang G; Wang L; Wang Z
Exp Cell Res; 2018 Mar; 364(2):198-207. PubMed ID: 29427622
[TBL] [Abstract][Full Text] [Related]
11. Profile of anterior gradient 3 (AGR3) mRNA expression and serum levels in benign and malignant breast tumors.
Prihantono P; Rahardjo W; Syamsu SA; Smaradhania N
Breast Dis; 2021; 40(S1):S39-S43. PubMed ID: 34057117
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of human anterior gradient protein 3.
Nguyen VD; Biterova E; Salin M; Wierenga RK; Ruddock LW
Acta Crystallogr F Struct Biol Commun; 2018 Jul; 74(Pt 7):425-430. PubMed ID: 29969106
[TBL] [Abstract][Full Text] [Related]
13. Differential expression of anterior gradient protein 3 in intrahepatic cholangiocarcinoma and hepatocellular carcinoma.
Brychtova V; Zampachova V; Hrstka R; Fabian P; Novak J; Hermanova M; Vojtesek B
Exp Mol Pathol; 2014 Jun; 96(3):375-81. PubMed ID: 24747240
[TBL] [Abstract][Full Text] [Related]
14. Anterior gradient proteins in gastrointestinal cancers: from cell biology to pathophysiology.
Boisteau E; Posseme C; Di Modugno F; Edeline J; Coulouarn C; Hrstka R; Martisova A; Delom F; Treton X; Eriksson LA; Chevet E; Lièvre A; Ogier-Denis E
Oncogene; 2022 Oct; 41(42):4673-4685. PubMed ID: 36068336
[TBL] [Abstract][Full Text] [Related]
15. TAE226-induced apoptosis in breast cancer cells with overexpressed Src or EGFR.
Golubovskaya VM; Virnig C; Cance WG
Mol Carcinog; 2008 Mar; 47(3):222-34. PubMed ID: 17849451
[TBL] [Abstract][Full Text] [Related]
16. Csk homologous kinase associates with RAFTK/Pyk2 in breast cancer cells and negatively regulates its activation and breast cancer cell migration.
McShan GD; Zagozdzon R; Park SY; Zrihan-Licht S; Fu Y; Avraham S; Avraham H
Int J Oncol; 2002 Jul; 21(1):197-205. PubMed ID: 12063569
[TBL] [Abstract][Full Text] [Related]
17. Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells.
Garcia R; Bowman TL; Niu G; Yu H; Minton S; Muro-Cacho CA; Cox CE; Falcone R; Fairclough R; Parsons S; Laudano A; Gazit A; Levitzki A; Kraker A; Jove R
Oncogene; 2001 May; 20(20):2499-513. PubMed ID: 11420660
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of Src activation with cardiotoxin III blocks migration and invasion of MDA-MB-231 cells.
Tsai PC; Chu CL; Chiu CC; Chang LS; Lin SR
Toxicon; 2013 Nov; 74():56-67. PubMed ID: 23933586
[TBL] [Abstract][Full Text] [Related]
19. SRC drives growth of antiestrogen resistant breast cancer cell lines and is a marker for reduced benefit of tamoxifen treatment.
Larsen SL; Laenkholm AV; Duun-Henriksen AK; Bak M; Lykkesfeldt AE; Kirkegaard T
PLoS One; 2015; 10(2):e0118346. PubMed ID: 25706943
[TBL] [Abstract][Full Text] [Related]
20. Src Is a Potential Therapeutic Target in Endocrine-Resistant Breast Cancer Exhibiting Low Estrogen Receptor-Mediated Transactivation.
Guest SK; Ribas R; Pancholi S; Nikitorowicz-Buniak J; Simigdala N; Dowsett M; Johnston SR; Martin LA
PLoS One; 2016; 11(6):e0157397. PubMed ID: 27308830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
